课题基金 / 基金详情

CONSTITUTIVE AND CYTOKINE-REGULATED EXPRESSION OF PRESENILIN-1 AND PRESENILIN-2 GENES IN HUMAN NEURAL CELL LINES

CONSTITUTIVE AND CYTOKINE-REGULATED EXPRESSION OF PRESENILIN-1 AND PRESENILIN-2 GENES IN HUMAN NEURAL CELL LINES
早老素 1 和早老素 2 基因在人神经细胞系中的组成型和细胞因子调节表达
批准号:
10670592
负责人:
SATOH Jun-ichi
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SATOH Jun-ichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To investigate the role of pleiotropic neuronal and glial cytokines in the regulation of presenilin (PS) gene expression in human neural cells, both presenilin-1 (PS1) and presenilin-2 (PS2) mRNA levels were analyzed by Northern blotting in SK-N-SH neuroblastoma, IMR-32 neuroblastoma, NTera2 teratocarcinoma-derived differentiated neurons (NTera2-N), and U-373MG astrocytoma cells following exposure to proinflammatory cytokines (TNF-α, IFN-γ, or IL-1β), anti -inflammatory cytokines (IL-10 or TGF-β1), dibutyryl cyclic AMP or phorbol 12-myristate 13-acetate (PMA). The constitutive expression of PS1 (3.0 kb) and PS2 (2.3 kb) mRNA was identified in all these cell lines, in which PS1 mRNA levels were unaltered following treatment with any cytokines and factors examined. By contrast, PS2 mRNA expression was up-regulated substantially in SK-N-SH cells by exposure to TNF-α and in U-373MG cells by treatment with IFN-γ, whereas it was down-regulated in both NTera2-N and U-373MG cells following exposure to IL-1βor PMA. The levels of PS2 mRNA remained unchanged in IMR-32 cells after these treatment. These results indicate that PS1 and PS2 genes are expressed constitutively in a panel of human neural cell lines where PS2 mRNA expression is affected by a distinct set of cytokines via cell type-specific mechanisms that do not alter PS1 mRNA levels, suggesting the existence of separated regulatory systems controlling the expression of PS1 and PS2 genes in human neural cells.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Satoh J et al: "Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines"Journal of Neuropathology and Experimental Neurology. 57. 131-139 (1998)
Satoh J等人:“人类神经细胞系中朊病毒蛋白基因的组成型和细胞因子诱导表达”神经病理学和实验神经病学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Satoh J et al.: "Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines"Journal of Neurpathology and Experimental Neurology. 57. 131-139 (1998)
Satoh J等人:“人类神经细胞系中朊病毒蛋白基因的组成型和细胞因子诱导表达”神经病理学和实验神经病学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Satoh J et al: "Constitutive and heat-inducible expression of HSP105 in neurons and glial cells in cultrue"Neuroreport. 9. 2977-2983 (1998)
Satoh J 等人:“培养物中神经元和神经胶质细胞中 HSP105 的组成型和热诱导表达”Neuroreport。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Satoh J et al.: "Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines"Journal of Neuropathology and Experimental Neurology. 57. 131-139 (1998)
Satoh J等人:“人神经细胞系中朊病毒蛋白基因的组成型和细胞因子诱导表达”神经病理学和实验神经学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
23
    Comprehensive analysis of TDP-43 target genes and binding proteins
    • 批准号:
      22500322
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.41万
    • 财政年份:
      2010
    • 负责人:
      SATOH Jun-ichi
    • 依托单位:
    Global Analysis of Human Prion Protein Interactors by Protein Microarray
    • 批准号:
      18300118
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.9万
    • 财政年份:
      2006
    • 负责人:
      SATOH Jun-ichi
    • 依托单位:
    Basic Research for Regenerative Therapy of Multiple Sclerosis
    PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTES IN CULTURE INDUCED BY A NEUROTROPHIC FACTOR PLEIOTROPHIN
    • 批准号:
      08670715
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1996
    • 负责人:
      SATOH Jun-ichi
    • 依托单位:
    国内基金
    海外基金
    基于“肝主泪”和Cytokines/P38MAPK/P53炎症相关通路的养阴润目丸治疗干眼的研究
    • 批准号:
      81674030
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2016
    • 负责人:
      李点
    • 依托单位:
    基于“功能药对分析模式”研究逍遥散抗抑郁作用的BDNF/HPA/cytokines靶位整合调节机制
    • 批准号:
      81503277
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2015
    • 负责人:
      刘蓉
    • 依托单位: